Zobrazeno 1 - 10
of 85
pro vyhledávání: '"Yuzuru Eto"'
Publikováno v:
Journal of Functional Foods, Vol 24, Iss , Pp 558-567 (2016)
A dietary peptide γ-glutamyl valine (EV) possesses the agonistic property to activate a calcium-sensing receptor-mediated anti-inflammatory pathway, thereby suppressing inflammation. This study aims to substantiate the therapeutic efficacy of γ-EV
Externí odkaz:
https://doaj.org/article/090d2c7e05a24d15a6a6ed1c7775ff69
Publikováno v:
PLoS ONE, Vol 7, Iss 4, p e34489 (2012)
Recently, we reported that calcium-sensing receptor (CaSR) is a receptor for kokumi substances, which enhance the intensities of salty, sweet and umami tastes. Furthermore, we found that several γ-glutamyl peptides, which are CaSR agonists, are koku
Externí odkaz:
https://doaj.org/article/c52d5661cdfe4c768bc732d7570039d2
Publikováno v:
Journal of Functional Foods, Vol 24, Iss, Pp 558-567 (2016)
A dietary peptide γ-glutamyl valine (EV) possesses the agonistic property to activate a calcium-sensing receptor-mediated anti-inflammatory pathway, thereby suppressing inflammation. This study aims to substantiate the therapeutic efficacy of γ-EV
Autor:
Yusuke Amino, Yutaka Maruyama, Takashi Miyaki, Masakazu Nakazawa, Yuzuru Eto, Naohiro Miyamura, Megumi Kaneko
Publikováno v:
CHEMICAL & PHARMACEUTICAL BULLETIN. 64:1181-1189
Modulation of the calcium sensing receptor (CaSR) is one of the physiological activities of γ-glutamyl peptides such as glutathione (γ-glutamylcysteinylglycine). γ-Glutamyl peptides also possess a flavoring effect, i.e., sensory activity of kokumi
Publikováno v:
Analytical Biochemistry. 472:45-51
Glucagon-like peptide-1 (GLP-1) is an incretin peptide that regulates islet hormone secretion. During recent years, incretin-based therapies have been widely used for patients with type 2 diabetes. GLP-1 peptides undergo N- and C-terminal processing
Autor:
Yuzuru Eto, Shingo Nakajima, Yoshiro Kitahara, Hiroshi Hara, Arimi Mitsunaga, Eri Sato, Tohru Hira, Maya Muramatsu
Publikováno v:
American Journal of Physiology-Gastrointestinal and Liver Physiology. 306:G1099-G1107
The calcium-sensing receptor (CaSR) is expressed in various tissues, including the gastrointestinal tract. To investigate the role of gut CaSR on glycemic control, we examined whether single oral administration of CaSR agonist peptides affected the g
Autor:
Toshimi Mizukoshi, Yumiko Kato, Motonaka Kuroda, Yuzuru Eto, Junko Yamazaki, Naohiro Miyamura, Hiroshi Miyano
Publikováno v:
Food Science and Technology Research. 20:699-703
Autor:
Junko Yamazaki, Motonaka Kuroda, Yuzuru Eto, Hiroshi Miyano, Toshimi Mizukoshi, Yuko Kai, Yumiko Kato
Publikováno v:
Food Chemistry. 141:823-828
Recent studies have demonstrated that kokumi substances, such as glutathione, are perceived through the calcium-sensing receptor (CaSR), and screening by CaSR assay and sensory evaluation has shown that γ-glutamyl-valyl-glycine (γ-Glu-Val-Gly) is a
Autor:
Hiroshi Miyano, Junko Yamazaki, Toshimi Mizukoshi, Motonaka Kuroda, Yuzuru Eto, Yumiko Kato, Yuko Kai
Publikováno v:
Journal of Agricultural and Food Chemistry. 60:7291-7296
It was recently reported that kokumi substances such as glutathione are perceived through the calcium-sensing receptor (CaSR). In addition, screening by the CaSR assay and sensory evaluation revealed that γ-glutamyl-valyl-glycine (γ-Glu-Val-Gly) wa
Publikováno v:
Biological and Pharmaceutical Bulletin. 34:671-676
A reduced incretin effect is one of the well-known characteristics of patients with type 2 diabetes, and impaired release of glucagon-like peptide-1 (GLP-1) has been reported to be at least partly involved. In this study, we investigated the effect o